How sputum clearance efficiency is assessed
The success of bronchial secretion elimination depends on several key factors:
- Rheological properties of sputum: these include its viscosity, elasticity, surface tension, osmolarity, and adhesiveness (stickiness).
- Volume of secretion: the total amount of mucus produced.
- Mucociliary clearance: the coordinated functional activity of the bronchial ciliated epithelium.
Mucolytics vs. secretomotor agents: what is the difference
In clinical practice, it is important to clearly distinguish between two approaches to liquefying sputum:
- Mucolytic agents act directly on the structure of the secretion. Their main effect is to reduce sputum viscosity and stickiness through depolymerization and degradation.
- Secretomotor agents work differently. They increase the volume of the liquid part of the secretion (which secondarily thins the mucus through dilution) and stimulate the motility of the ciliated epithelium by activating the movement of its cilia.
Classification of mucolytics by composition
The modern pharmacological arsenal of mucolytic drugs is divided into two broad categories:
- Synthetic drugs: acetylcysteine, carbocisteine, ambroxol, and bromhexine, which are well known to physicians and students.
- Enzymatic drugs: used less frequently as mucolytics and subdivided into proteolytic enzymes (trypsin, chymotrypsin) and nucleases (ribonuclease, deoxyribonuclease).
Features of enzymatic mucolytics
Enzymatic drugs have specific mechanisms of action on bronchial secretions:
- Proteolytic enzymes (trypsin, chymotrypsin) cleave peptide bonds directly within the protein portion of sputum.
- Nucleases (RNase, DNase) cause depolymerization of nucleic acids—DNA and RNA—which accumulate in large amounts in pus and decaying cells.
A prominent representative of this subgroup is recombinant alpha-deoxyribonuclease (α-DNase), known under the trade name Pulmozyme (Pulmozyme). This drug is administered via inhalation.
Briefly: answers to topical questions
What is the mechanism of action of acetylcysteine?
The mechanism of action of acetylcysteine involves the direct destruction of the sputum structure through the cleavage of disulfide bonds.
- Direct action — free sulfhydryl groups (-SH) cleave disulfide bonds in sputum proteoglycans, causing depolymerization of macromolecules and a decrease in secretion viscosity.
- Additional effects — stimulation of mucous cell secretion, fibrinolysis, antioxidant, anti-inflammatory, and detoxifying effects (stimulation of glutathione synthesis).
What is the mechanism of action of ambroxol?
The mechanism of action of ambroxol is based on the drug's effect on endogenous surfactant.
- Stimulation of production — enhances the synthesis of the surface-active substance (surfactant), which prevents alveolar collapse and possesses bactericidal properties.
- Reduction of degradation — decreases the degradation of endogenous surfactant.
As a result of these processes, the rheological properties of sputum change (it becomes liquefied) and the elimination of secretions from the airways is significantly facilitated (expectorant effect).
What are the indications for the use of alpha-DNase (Pulmozyme)?
Recombinant $\alpha$-deoxyribonuclease (Pulmozyme) is used as basic mucolytic therapy. The main indications for prescribing the drug are:
- Cystic fibrosis — for sputum thinning, including attempts to resolve lobar atelectasis when conservative therapy is ineffective.
- Widespread bronchiectasis — administered via inhalation using a nebulizer.
- Chronic polypoid rhinosinusitis — prescribed for inhalation and via pulsating aerosol delivery systems into the nasal passages.
What are the contraindications to the prescription of mucolytic agents?
Contraindications and limitations to prescribing mucolytics depend on the specific drug and treatment regimen.
- Combination with antitussives — simultaneous use is not recommended, as suppression of the cough reflex against the background of expectorants can lead to sputum stagnation.
- Bromhexine — contraindicated during pregnancy and breastfeeding.
- Mannitol — contraindicated in children under 6 years of age.
- In cystic fibrosis, the presence of individual medical contraindications serves as a contraindication.
Mucolytics break down mucus molecules (sputum thins), while secretomotors drive it toward the exit using cilia.
Class and exam questions
How do mucolytic agents differ from secretomotor agents?
Mucolytics disrupt the structure of sputum and reduce its viscosity through chemical depolymerization. Secretomotor agents increase the volume of the liquid component of the secretion and activate the movement of the ciliated epithelium.
What are the main groups included in mucolytics?
Mucolytic agents are divided into two groups: synthetic drugs (e.g., acetylcysteine and ambroxol) and enzymatic drugs (proteolytic enzymes and nucleases).
How do enzymatic mucolytic agents work?
Proteolytic enzymes cleave peptide bonds in sputum proteins, while nucleases depolymerize nucleic acids (DNA and RNA) contained in pus and destroyed cells.
What else to study on this topic
- Rheological properties of sputum: viscosity, elasticity, and adhesiveness
- Mechanisms of mucociliary clearance in airway pathology
- Comparative characteristics of synthetic mucolytics (acetylcysteine and carbocisteine)
- Pharmacodynamics of proteolytic enzymes and nucleases in pulmonology
- Features of the inhalation use of alpha-deoxyribonuclease
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Mucolytic agents» and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section 'Drugs acting on respiratory system functions'
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.